Core Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Core Wealth Partners's PFE Position: Q2 2026 in Review
Core Wealth Partners increased its Pfizer (PFE) stake by 0.75% in Q2 2026, buying an estimated $2.25K and bringing the position to 11,587 shares worth $279K. The position accounts for 0.12% of the portfolio, ranked #143.
Core Wealth Partners first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $854K in Q4 2022. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Core Wealth Partners held 11,587 shares of Pfizer worth $279K as of Q2 2026.
- Core Wealth Partners bought 86 Pfizer shares in Q2 2026, an estimated $2.25K.
- Pfizer made up 0.12% of Core Wealth Partners's portfolio in Q2 2026, its #143 holding.
- Core Wealth Partners first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- Core Wealth Partners's Pfizer position peaked at $854K in Q4 2022.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Core Wealth Partners's 13F filing for Q2 2026, filed 17 Jul 2026.